1.2.1.3	(2E)-4-hydroxy-2-nonenal + NAD+ + H2O	-	Rattus norvegicus	(2E)-4-hydroxy-2-nonenoic acid + NADH + H+	-	?	399143	
1.2.1.3	(2E)-4-hydroxy-2-nonenal + NAD+ + H2O	-	Bos taurus	(2E)-4-hydroxy-2-nonenoic acid + NADH + H+	-	?	399143	
1.2.1.3	(E)-2-nonenal + NAD+ + H2O	-	Arabidopsis thaliana	(E)-non-2-enoate + NADH + H+	-	?	427130	
1.2.1.3	(R)-N-(3-(6-(4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b] thiophene-2-carboxamide + H2O + O2	i.e. GDC-0834, a Bruton's tyrosine kinase inhibitor, a potential treatment of rheumatoid arthritis. GDC-0834	Homo sapiens	?	compound is extensively metabolized by amide hydrolysis by both aldehyde oxidase and carboxylesterase	?	438562	
1.2.1.3	(R)-trans-4-hydroxy-2-nonenal + NAD+ + H2O	-	Rattus norvegicus	(2E,4R)-4-hydroxynon-2-enoic acid + NADH + H+	-	?	399212	
1.2.1.3	(R)-trans-4-hydroxy-2-nonenal + NAD+ + H2O	ALDH5A enantioselectively oxidizes (R)-trans-4-hydroxy-2-nonenal	Rattus norvegicus	(2E,4R)-4-hydroxynon-2-enoic acid + NADH + H+	-	?	399212	
1.2.1.3	(S)-trans-4-hydroxy-2-nonenal + NAD+ + H2O	-	Rattus norvegicus	(2E,4S)-4-hydroxynon-2-enoic acid + NADH + H+	-	?	399238	
1.2.1.3	1,3-dihydroxyacetone + NAD+ + H2O	53.93% activity compared to acetaldehyde	Sulfurisphaera tokodaii	? + NADH + H+	-	?	422249	
1.2.1.3	1-formyl-6-methylpyrene + NAD+	-	Homo sapiens	6-methylpyrene 1-carboxylate + NADH + H+	-	?	395244	
1.2.1.3	1-formyl-6-methylpyrene + NAD+ + H2O	-	Homo sapiens	6-methylpyrene-1-carboxylic acid + NADH + H+	-	?	399268